In-transit lymph node metastases in breast cancer: A possible source of local recurrence after Sentinel Node procedure

Journal of Clinical Pathology

Volumn 61, Issue 12, 2008, Pages 1314-1316

  Van Deurzen, C H M ^a   Borgstein, P J ^b   Van Diest, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IN-TRANSIT METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY;

EID: 57549115434     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.059600     Document Type: Article

References (11)

1. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-98; discussion 398-401.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-6.
3. Borgstein PJ, Pijpers A, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
4. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
5. Uren RF, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 2000;135:1168-72.
6. McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg 2002;137:543-47; discussion 547-9.
7. Thelmo MC, Morita ET, Treseler PA, et al. Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma. Ann Surg Oncol 2001;8:444-8.
8. Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging 2004;31:945-9.
9. Statius Muller MG, van Leeuwen PA, van Diest PJ, et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. World J Surg 2002;26:1405-11.
10. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999;52:871-3.
11. van Diest PJ, Peterse HL, Borgstein PJ, et al. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999;26(4 Suppl):43-9S.